NASDAQ: KA - Kineta, Inc.

六个月盈利: -18.63%
部门: Healthcare

促销时间表 Kineta, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司

Kineta, Inc., a clinical-stage biotechnology company, develops immunotherapies in the field of immuno-oncology, cancer, neurology, and arenaviruses. The company is developing KVA12123, an anti-VISTA antagonist mAb immunotherapy, which is in Phase 1/2 clinical trials for the treatment of solid tumors, including non-small cell lung cancer, ovarian cancer, colorectal cancer, colon cancer, pancreatic cancer, and gastric cancer.

更多详情
It is also developing anti-CD27 agonist mAb immunotherapy, which is in Phase 1 clinical trials for the treatment of advanced solid tumors, such as renal cell carcinoma, ovarian cancer, and colorectal cancer. In addition, the company develops immunotherapies for pain management and anti-viral therapy for the treatment of emerging diseases. Kineta, Inc. has collaboration and license agreements with MSD International Business GmbH, and GigaGen, Inc. The company was formerly known as Lecura, Inc. Kineta, Inc. was founded in 2007 and is headquartered in Seattle, Washington.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

EBITDA -0.0597
EV/EBITDA -1.78
IPO date 2016-02-11
ISIN US49461C1027
Industry Biotechnology
P/BV 1.89
P/S 23.63
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 0.005
Див.доход ао 0
Дивиденд ао 10.01
Сайт https://kinetabio.com
Цена ао 0.5521
Число акций ао 0.01105 млрд
每日价格变化: 0% (0.4801)
每周价格变化: 0% (0.4801)
每月价格变化: 0% (0.4801)
3个月内价格变化: -14.27% (0.56)
六个月内的价格变化: -18.63% (0.59)
每年价格变化: -86.77% (3.63)
3年内价格变化: -85.09% (3.22)
5年内价格变化: -74.6% (1.89)
10年价格变化: 0% (0.4801)
年初以来价格变化: 0% (0.4801)
所有参数

低估

姓名 意义 年级
P/S 8.12 1
P/BV 14.45 1
P/E 0 0
EV/EBITDA -2.52 0
全部的: 4

效率

姓名 意义 年级
ROA, % -137.14 0
ROE, % -487.85 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0.5 5
全部的: 2.35

责任

姓名 意义 年级
Debt/EBITDA -0.0838 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 8.84 2
盈利能力 Ebitda, % -73.68 0
盈利能力 EPS, % -99.21 0
全部的: 0.4
更多详情

机构 体积 分享, %
Armistice Capital, LLC 825792 7.53
Vanguard Group Inc 151380 1.38
FMR, LLC 123719 1.13
Geode Capital Management, LLC 50584 0.46
Northern Trust Corporation 36880 0.34
Stifel Financial Corporation 21853 0.2
Financial Advocates Investment Management 21744 0.2
Blackrock Inc. 19957 0.18
Renaissance Technologies, LLC 19044 0.17
ELEMENT POINTE ADVISORS, LLC 17696 0.16



导师 职称 支付 出生年份
Mr. Craig W. Philips President & Secretary 541.67k 1961 (64 年)
Ms. Pauline Kenny Esq., J.D. Advisor 349.72k 1974 (51 年)
Mr. Keith A. Baker Chief Financial Officer 485.75k 1967 (58 年)
Dr. Thierry Guillaudeux Ph.D. Chief Scientific Officer N/A 1968 (57 年)
Mr. Gary Gentges Executive Vice President of Corporate Development

地址: United States, Seattle. WA, 219 Terry Ave. N - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://kinetabio.com